These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 478242)

  • 21. [The allergic-reactive and encephalitogenic potential of rabies vaccines prepared from different virulent materials].
    Serban O; Toacsen E; Ionescu T; Potorac E; Anghelescu N; Bunea M
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1982; 27(2):97-107. PubMed ID: 6128780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of rabies vaccine prepared from tissue cultures for complementary and prophylactic vaccination of humans].
    Selimow MA; Aksjonowa TA; Miedwiedjew WD; Kostiukow WP; Szustikow GG; Strygina NP; Stiepanowa IA; Michajlowskij EM; Piecznikowa ZB; Fursowa AA; Kuzniecowa AM
    Przegl Epidemiol; 1970; 24(1):41-8. PubMed ID: 5431387
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antirabies vaccine from human diploid cells initial vaccination experiences].
    Oberti G; Canepa F
    G Batteriol Virol Immunol; 1983; 76(1-6):148-56. PubMed ID: 6679481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pathogenicity of oral rabies vaccine residues].
    Ross RS; Roggendorf M
    Dtsch Med Wochenschr; 1998 Feb; 123(9):271. PubMed ID: 9524541
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antirabies vaccination and the responsibility of public authorities].
    Doll PJ
    Nouv Presse Med; 1978 Feb; 7(6):476. PubMed ID: 634790
    [No Abstract]   [Full Text] [Related]  

  • 26. [Neurological complications associated with anti-rabies vaccination in São Paulo: therapeutic, clinical and epidemiological aspects of 59 cases].
    Saraiva PA; de Assis JL; Tiriba Ada C
    Rev Paul Med; 1972 Aug; 80(2):63-70. PubMed ID: 4671574
    [No Abstract]   [Full Text] [Related]  

  • 27. Purified chick embryo cell (PCEC) rabies vaccine for human use: clinical trials.
    Bijok U; Vodopija I; Smerdel S; Thongcharoen P; Nicholson K; Dietrich M; Gonzalez de Cosio A
    Behring Inst Mitt; 1984 Nov; (76):155-64. PubMed ID: 6395850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine.
    Briggs DJ; Banzhoff A; Nicolay U; Sirikwin S; Dumavibhat B; Tongswas S; Wasi C
    Bull World Health Organ; 2000; 78(5):693-8. PubMed ID: 10859864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three-year experience with 4-site intradermal booster vaccination with rabies vaccine for postexposure prophylaxis.
    Tantawichien T; Tantawichien T; Supit C; Khawplod P; Sitprija V
    Clin Infect Dis; 2001 Dec; 33(12):2085-7. PubMed ID: 11712097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Reactions to and complications following rabies vaccination in 1974 in the Lublin Province].
    Radomińska I; Magryta L; Modrzewska R
    Pol Tyg Lek; 1976 Jan; 31(3):109-12. PubMed ID: 1257117
    [No Abstract]   [Full Text] [Related]  

  • 31. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen.
    Madhusudana SN; Sanjay TV; Mahendra BJ; Suja MS
    Int J Infect Dis; 2004 May; 8(3):175-9. PubMed ID: 15109593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neurological complications after the administration of newborn mouse brain antirabies vaccine].
    Held JR; López Adaros H
    Bol Oficina Sanit Panam; 1971 Jul; 71(1):50-9. PubMed ID: 4254526
    [No Abstract]   [Full Text] [Related]  

  • 33. [Post-vaccination reactions to diploid rabies vaccine].
    Majchrowicz H
    Przegl Epidemiol; 1989; 43(3):259-62. PubMed ID: 2616798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Rabies vaccine in Czechoslovakia. I. Hempt's vaccine and its modification].
    Slonim D; Stastný F; Brázdová AR
    Cesk Epidemiol Mikrobiol Imunol; 1982 Sep; 31(5):257-65. PubMed ID: 6215991
    [No Abstract]   [Full Text] [Related]  

  • 35. Guillain-Barre syndrome following antirabies vaccine.
    Udawat H; Nayak R; Chaudhary HR; Goyal RK
    J Assoc Physicians India; 2000 May; 48(5):538-9. PubMed ID: 11273154
    [No Abstract]   [Full Text] [Related]  

  • 36. [Aspects of the immunogenic capacities of the fixed Babeş rabies virus to vaccines prepared from nerve tissue of different categories of experimental animals].
    Serban O; Toacsen E; Potorac E; Bunea M; Pandele E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1983; 28(1):41-8. PubMed ID: 6635460
    [No Abstract]   [Full Text] [Related]  

  • 37. Benefit versus risk factors in prophylactic vaccination against rabies.
    Bahmanyar M
    Dev Biol Stand; 1979; 43():305-7. PubMed ID: 520677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The problem of rabies vaccination in children; an analysis of children bitten by rabid and rabid-suspected-animals.
    Munir M
    Paediatr Indones; 1980; 20(7-8):157-68. PubMed ID: 7443278
    [No Abstract]   [Full Text] [Related]  

  • 39. Five-year longitudinal study of efficacy and safety of purified Vero cell rabies vaccine for post-exposure prophylaxis of rabies in Indian population.
    Seghal S; Bhattacharya D; Bhardwaj M
    J Commun Dis; 1997 Mar; 29(1):23-8. PubMed ID: 9282525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-exposure prophylaxis with purified vero cell rabies vaccine during pregnancy--safety and immunogenicity.
    Sudarshan MK; Madhusudana SN; Mahendra BJ
    J Commun Dis; 1999 Dec; 31(4):229-36. PubMed ID: 10937299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.